Evommune (EVMN) Earnings Date, Estimates & Call Transcripts $22.74 -0.81 (-3.46%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$22.90 +0.16 (+0.70%) As of 05/22/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Evommune Earnings Summary Evommune issued Q1 2026 earnings on May 7, 2026, reporting an EPS of -$0.64, which topped the consensus estimate of -$0.83 by $0.19. With a trailing EPS of -$9.50, Evommune's earnings are expected to decrease next year, from ($2.86) to ($3.52) per share. Consensus EPS (May. 7) -$0.83 Actual EPS (May. 7) -$0.64 Beat By $0.19 Q1 2026 Earnings ResourcesQ1 2026 Earnings Report Press Release (8-K) Quarterly Report (10-Q)Powered by Get Evommune Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Evommune and other key companies, straight to your inbox. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataEVMN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Evommune Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20262-$0.83-$0.66-$0.75Q2 20262-$0.71-$0.63-$0.67Q3 20262-$0.71-$0.56-$0.64Q4 20262-$0.75-$0.75-$0.75 Evommune Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/7/2026Q1 2026-$0.83-$0.64+$0.19-$0.64--3/5/2026Q4 2025-$0.82-$1.43 -$0.61-$1.43--12/11/2025Q3 2025-$6.58-$8.07 -$1.49-$8.07$10.00M$10.00M Data powered by Fiscal.ai. Evommune Earnings - Frequently Asked Questions When did Evommune announce their last quarterly earnings? Evommune (NYSE:EVMN) last announced its quarterly earning data on Thursday, May 7, 2026. Learn more on EVMN's earnings history. Did Evommune beat their earnings estimates last quarter? In the previous quarter, Evommune (NYSE:EVMN) reported ($0.64) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.83) by $0.19. Learn more on analysts' earnings estimate vs. EVMN's actual earnings. How much revenue does Evommune generate each year? Evommune (NYSE:EVMN) has a recorded annual revenue of $10 million. How much profit does Evommune generate each year? Evommune (NYSE:EVMN) has a recorded net income of -$68.87 million. EVMN has generated -$9.50 earnings per share over the last four quarters. What is Evommune's EPS forecast for next year? Evommune's earnings are expected to decrease from ($2.86) per share to ($3.52) per share in the next year. More Earnings Resources from MarketBeat Related Companies Beam Therapeutics Earnings Results Erasca Earnings Results Oruka Therapeutics Earnings Results Alumis Earnings Results Arcus Biosciences Earnings Results Denali Therapeutics Earnings Results Dyne Therapeutics Earnings Results Vera Therapeutics Earnings Results Tarsus Pharmaceuticals Earnings Results Arcutis Biotherapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?Workday Validates AI Flywheel: Stock Price Recovery BeginsOverextended, e.l.f. Beauty Is Primed to Rebound in Back HalfDeere Beats Q2 Estimates, But Ag Weakness Weighs on OutlookNVIDIA Price Pullback? Don’t Count on It, Business Is AcceleratingMeta Platforms 10% Layoff Raises a Bigger Question About AI SpendingBiogen Stock Slides After Trial Miss, But Analysts Stay Bullish This page (NYSE:EVMN) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...Brownstone Research | SponsoredBefore you buy SpaceX shares, consider this alternative approachSpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...Weiss Ratings | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evommune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evommune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
